Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Three Detection Methods Compared for Malaria Gametocytes

By Labmedica International staff writers
Posted on 28 Aug 2014
Print article
Image: Blood smear showing a male gametocyte of Plasmodium vivax (Photo courtesy of Dr. Mae Melvin).
Image: Blood smear showing a male gametocyte of Plasmodium vivax (Photo courtesy of Dr. Mae Melvin).
Image: Magnetic-activated cell sorting (MACS) equipment (Photo courtesy the University of South Carolina).
Image: Magnetic-activated cell sorting (MACS) equipment (Photo courtesy the University of South Carolina).
Gametocytes are the transmission stages of malaria parasites and as their density in the human host is typically low, they are often undetected by conventional light microscopy.

A detailed comparison of three methods, namely light microscopy, magnetic fractionation (MF) and reverse transcriptase polymerase chain reaction (RT-PCR) for detection of Plasmodium falciparum and P. vivax gametocytes has been conducted.

Scientists at the University of Western Australia (Fremantle, Australia) working with an international team took blood samples from total of 70 children, 56 with P. falciparum and 14 with P. vivax and aged between six months and five years. For the light microscopy Giemsa-stained thick blood smears were examined and parasite density quantified independently by two skilled microscopists with parasites counted against 500 white cells.

For the MF study the samples were subjected to high field gradient MF and magnetic particles (Spherotech; Lake Forest, IL, USA) were added to achieve a total known particle concentration of 100 particles per μL of blood. The samples were then magnetically fractionated using magnetic-activated cell sorting (MACS) equipment (Miltenyi Biotec; Bergisch Gladbach, Germany). For the RT-PCR study the team used the P. falciparum Pfs25 gene or the P. vivax Pvs25 gene copy number as a measure for gametocyte abundance. All RT-PCR assays were run in 384-well plate format on the LightCycler480 platform (Roche; Basel, Switzerland).

The scientists found that MF and RT-PCR were similarly sensitive and specific, and both were superior to light microscopy (LM). Overall, there were approximately 20% gametocyte-positive samples by LM, whereas gametocyte positivity by MF and RT-PCR were both more than two-fold this level. In the subset of samples collected prior to treatment, 29% of children were positive by LM, and 85% were gametocyte positive by MF and RT-PCR, respectively. MF is a feasible methodology for field-based gametocyte detection that can be applied even in larger scale studies. With an appropriate set- up, four to six samples could conveniently be processed by one person in an hour with results being available for all samples after approximately 90 minutes.

The authors concluded that that magnetic fractionation is a very good alternative method for on-site gametocyte detection under field conditions. The method has, as previously shown under laboratory conditions, similar sensitivity to RT-PCR and can be used to derive quantitative gametocyte densities for both P. falciparum and P. vivax. The study was published on August 14, 2014, in the Malaria Journal.

Related Links:

University of Western Australia
Spherotech
Miltenyi Biotec




Print article
Abbott Diagnostics

Channels

Lab Tech.

view channel
Image: The nano-DLD chip (2 cm x 2 cm) mounted in a microfluidic jig. The technology allows a liquid sample to be passed, in continuous flow, through a silicon chip containing an asymmetric pillar array that allows sorting a microscopic waterfall of nanoparticles, separating particles by size down to 20 nanometer resolution (Photo courtesy of IBM Research).

Lab-on-a-Chip Technology Breaks New Bioparticle Separation Record

Scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale down to 20 nanometers in diameter, a scale that gives access to important... Read more

Industry News

view channel

Critical Care Diagnostics Market Worth USD 1.29 Billion By 2024

The global critical care diagnostics (CCD) market will grow at a lucrative rate over the next few years to reach USD 1.29 billion by 2024, driven by the rapid awareness and acknowledgment of these tests by physicians and patients, rise in geriatric population and chronic health conditions, use of telehealth services in... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.